Advertisement
Screener

IRADIMED CORPORATION (IRMD) Net Income

IRADIMED CORPORATION Net Income

IRADIMED CORPORATION (IRMD) reported Net Income of $5.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.

Financial Statements › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2026-07-31

  • IRADIMED CORPORATION net income (loss) attributable to parent for the quarter ending 2026-06-30 was $5.22M, a 9.63% decline year-over-year.
  • IRADIMED CORPORATION net income (loss) attributable to parent for the quarter ending 2026-03-31 was $5.82M, a 24.13% increase year-over-year.
  • IRADIMED CORPORATION net income (loss) attributable to parent for the quarter ending 2025-12-31 was $6.44M, a 25.17% increase year-over-year.
  • IRADIMED CORPORATION net income (loss) attributable to parent for the quarter ending 2025-09-30 was $5.58M, a 10.44% increase year-over-year.
  • IRADIMED CORPORATION net income (loss) attributable to parent for fiscal 2022 was $12.83M, a 37.56% increase from fiscal 2021.
  • IRADIMED CORPORATION net income (loss) attributable to parent for fiscal 2021 was $9.33M, a 581.19% increase from fiscal 2020.
  • IRADIMED CORPORATION net income (loss) attributable to parent for fiscal 2020 was $1.37M, a 85.79% decline from fiscal 2019.
  • IRADIMED CORPORATION net income (loss) attributable to parent for fiscal 2019 was $9.63M, a 52.79% increase from fiscal 2018.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 3 month as first filedNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 6 month as first filedNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 12 monthNet Income (Loss) Attributable to Parent 12 month as first filed
2026-06-30$5.22M
10-Q · filed 2026-07-31
$11.04M
10-Q · filed 2026-07-31
$17.48M
derived: sum of 3 quarters · filed 2026-07-31
$23.05M
derived: sum of 4 quarters · filed 2026-07-31
2026-03-31$5.82M
10-Q · filed 2026-07-31
$12.26M
derived: sum of 2 quarters · filed 2026-07-31
$17.84M
derived: sum of 3 quarters · filed 2026-07-31
$23.61M
derived: sum of 4 quarters · filed 2026-07-31
2025-12-31$6.44M
derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-30
$12.02M
derived: sum of 2 quarters · filed 2026-04-30
$17.79M
derived: sum of 3 quarters · filed 2026-07-31
$22.48M
DEF 14A · filed 2026-04-30
$22.48M
10-K · filed 2026-03-06
2025-09-30$5.58M
10-Q · filed 2025-11-03
$11.35M
derived: sum of 2 quarters · filed 2026-07-31
$16.04M
10-Q · filed 2025-11-03
$21.18M
derived: sum of 4 quarters · filed 2026-07-31
2025-06-30$5.77M
10-Q · filed 2026-07-31
$5.77M
10-Q · filed 2025-08-01
$10.46M
10-Q · filed 2026-07-31
$10.46M
10-Q · filed 2025-08-01
$15.61M
derived: sum of 3 quarters · filed 2026-07-31
$20.66M
derived: sum of 4 quarters · filed 2026-07-31
2025-03-31$4.69M
10-Q · filed 2026-07-31
$4.69M
10-Q · filed 2025-05-05
$9.83M
derived: sum of 2 quarters · filed 2026-07-31
$14.88M
derived: sum of 3 quarters · filed 2026-07-31
$19.78M
derived: sum of 4 quarters · filed 2026-07-31
2024-12-31$5.15M
derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-30
$10.20M
derived: sum of 2 quarters · filed 2026-04-30
$15.10M
derived: sum of 3 quarters · filed 2026-04-30
$19.23M
DEF 14A · filed 2026-04-30
2024-09-30$5.05M
10-Q · filed 2025-11-03
$9.95M
derived: sum of 2 quarters · filed 2025-11-03
$14.09M
10-Q · filed 2025-11-03
$18.63M
derived: sum of 4 quarters · filed 2026-04-30
2024-06-30$4.90M
10-Q · filed 2025-11-03
$9.04M
10-Q · filed 2025-08-01
$13.58M
derived: sum of 3 quarters · filed 2026-04-30
$18.64M
derived: sum of 4 quarters · filed 2026-04-30
2024-03-31$4.14M
10-Q · filed 2025-11-03
$8.68M
derived: sum of 2 quarters · filed 2026-04-30
$13.74M
derived: sum of 3 quarters · filed 2026-04-30
$17.92M
derived: sum of 4 quarters · filed 2026-04-30
2023-12-31$4.54M
derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-30
$9.61M
derived: sum of 2 quarters · filed 2026-04-30
$13.79M
derived: sum of 3 quarters · filed 2026-04-30
$17.19M
DEF 14A · filed 2026-04-30
2023-09-30$5.07M
10-Q · filed 2024-10-31
$9.25M
derived: sum of 2 quarters · filed 2024-10-31
$12.65M
10-Q · filed 2024-10-31
$16.33M
derived: sum of 4 quarters · filed 2024-10-31
2023-06-30$4.18M
10-Q · filed 2024-10-31
$7.59M
10-Q · filed 2024-08-01
$11.26M
derived: sum of 3 quarters · filed 2024-10-31
$14.69M
derived: sum of 4 quarters · filed 2024-10-31
2023-03-31$3.41M
10-Q · filed 2024-10-31
$3.41M
10-Q · filed 2023-05-04
$7.08M
derived: sum of 2 quarters · filed 2024-10-31
$10.51M
derived: sum of 3 quarters · filed 2024-10-31
$13.75M
derived: sum of 4 quarters · filed 2024-10-31
2022-12-31$3.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01
$7.10M
derived: sum of 2 quarters · filed 2024-03-01
$10.34M
derived: sum of 3 quarters · filed 2024-03-01
$12.83M
10-K · filed 2024-03-01
2022-09-30$3.43M
10-Q · filed 2023-11-03
$6.67M
derived: sum of 2 quarters · filed 2023-11-03
$9.15M
10-Q · filed 2023-11-03
$13.05M
derived: sum of 4 quarters · filed 2023-11-03
2022-06-30$3.24M
10-Q · filed 2023-11-03
$5.73M
10-Q · filed 2023-08-03
$9.62M
derived: sum of 3 quarters · filed 2023-11-03
$12.20M
derived: sum of 4 quarters · filed 2023-11-03
2022-03-31$2.49M
10-Q · filed 2023-11-03
$6.38M
derived: sum of 2 quarters · filed 2023-11-03
$8.96M
derived: sum of 3 quarters · filed 2023-11-03
$10.43M
derived: sum of 4 quarters · filed 2023-11-03
2021-12-31$3.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02
$6.47M
derived: sum of 2 quarters · filed 2023-03-02
$7.94M
derived: sum of 3 quarters · filed 2023-03-02
$9.33M
10-K · filed 2023-03-02
2021-09-30$2.58M
10-Q · filed 2022-11-03
$4.05M
derived: sum of 2 quarters · filed 2022-11-03
$5.43M
10-Q · filed 2022-11-03
$6.07M
derived: sum of 4 quarters · filed 2022-11-03
2021-06-30$1.47M
10-Q · filed 2022-11-03
$2.86M
10-Q · filed 2022-08-05
$3.49M
derived: sum of 3 quarters · filed 2022-11-03
$4.57M
derived: sum of 4 quarters · filed 2022-11-03
2021-03-31$1.39M
10-Q · filed 2022-11-03
$2.02M
derived: sum of 2 quarters · filed 2022-11-03
$3.10M
derived: sum of 3 quarters · filed 2022-11-03
$986.64K
derived: sum of 4 quarters · filed 2022-11-03
2020-12-31$637.41K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04
$1.71M
derived: sum of 2 quarters · filed 2022-03-04
-$400.21K
derived: sum of 3 quarters · filed 2022-03-04
$1.37M
10-K · filed 2022-03-04
2020-09-30$1.07M
10-Q · filed 2021-11-05
-$1.04M
derived: sum of 2 quarters · filed 2021-11-05
$731.59K
10-Q · filed 2021-11-05
$3.97M
derived: sum of 4 quarters · filed 2022-03-04
2020-06-30-$2.11M
10-Q · filed 2021-11-05
-$343.06K
10-Q · filed 2021-08-06
$2.90M
derived: sum of 3 quarters · filed 2022-03-04
$5.35M
derived: sum of 4 quarters · filed 2022-03-04
2020-03-31$1.77M
10-Q · filed 2021-11-05
$5.01M
derived: sum of 2 quarters · filed 2022-03-04
$7.47M
derived: sum of 3 quarters · filed 2022-03-04
$9.55M
derived: sum of 4 quarters · filed 2022-03-04
2019-12-31$3.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04
$5.70M
derived: sum of 2 quarters · filed 2022-03-04
$7.79M
derived: sum of 3 quarters · filed 2022-03-04
$9.63M
10-K · filed 2022-03-04
2019-09-30$2.45M
10-Q · filed 2020-11-06
$4.54M
derived: sum of 2 quarters · filed 2020-11-06
$6.39M
10-Q · filed 2020-11-06
$8.10M
derived: sum of 4 quarters · filed 2021-03-05
2019-06-30$2.09M
10-Q · filed 2020-11-06
$3.93M
10-Q · filed 2020-08-06
$5.64M
derived: sum of 3 quarters · filed 2021-03-05
$8.04M
derived: sum of 4 quarters · filed 2021-03-05
2019-03-31$1.85M
10-Q · filed 2020-11-06
$3.55M
derived: sum of 2 quarters · filed 2021-03-05
$5.95M
derived: sum of 3 quarters · filed 2021-03-05
$7.31M
derived: sum of 4 quarters · filed 2021-03-05
2018-12-31$1.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05
$4.11M
derived: sum of 2 quarters · filed 2021-03-05
$5.46M
derived: sum of 3 quarters · filed 2021-03-05
$6.30M
10-K · filed 2021-03-05
2018-09-30$2.40M
10-Q · filed 2019-11-07
$3.76M
derived: sum of 2 quarters · filed 2019-11-07
$4.60M
10-Q · filed 2019-11-07
$4.78M
derived: sum of 4 quarters · filed 2020-03-06
2018-06-30$1.35M
10-Q · filed 2019-08-07
$2.20M
10-Q · filed 2019-08-07
$2.38M
derived: sum of 3 quarters · filed 2020-03-06
$2.57M
derived: sum of 4 quarters · filed 2020-03-06
2018-03-31$841.20K
10-Q · filed 2019-05-08
$1.02M
derived: sum of 2 quarters · filed 2020-03-06
$1.22M
derived: sum of 3 quarters · filed 2020-03-06
$1.57M
derived: sum of 4 quarters · filed 2020-03-06
2017-12-31$183.64K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06
$376.03K
derived: sum of 2 quarters · filed 2020-03-06
$733.10K
derived: sum of 3 quarters · filed 2020-03-06
$499.76K
10-K · filed 2020-03-06
2017-09-30$192.39K
10-Q · filed 2018-11-07
$549.47K
derived: sum of 2 quarters · filed 2018-11-07
$316.13K
10-Q · filed 2018-11-07
$1.46M
derived: sum of 4 quarters · filed 2019-03-07
2017-06-30$357.07K
10-Q · filed 2018-08-08
$123.73K
10-Q · filed 2018-08-08
$1.26M
derived: sum of 3 quarters · filed 2019-03-07
$2.83M
derived: sum of 4 quarters · filed 2019-03-07
2017-03-31-$233.34K
10-Q · filed 2018-05-08
$907.46K
derived: sum of 2 quarters · filed 2019-03-07
$2.47M
derived: sum of 3 quarters · filed 2019-03-07
$4.70M
derived: sum of 4 quarters · filed 2019-03-07
2016-12-31$1.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
$2.70M
derived: sum of 2 quarters · filed 2019-03-07
$4.93M
derived: sum of 3 quarters · filed 2019-03-07
$7.21M
10-K · filed 2019-03-07
2016-09-30$1.56M
10-Q · filed 2017-11-06
$3.79M
derived: sum of 2 quarters · filed 2017-11-06
$6.07M
10-Q · filed 2017-11-06
$8.48M
derived: sum of 4 quarters · filed 2018-03-08
2016-06-30$2.23M
10-Q · filed 2017-08-04
$4.51M
10-Q · filed 2017-08-04
$6.92M
derived: sum of 3 quarters · filed 2018-03-08
$8.79M
derived: sum of 4 quarters · filed 2018-03-08
2016-03-31$2.28M
10-Q · filed 2017-05-05
$4.69M
derived: sum of 2 quarters · filed 2018-03-08
$6.55M
derived: sum of 3 quarters · filed 2018-03-08
$8.32M
derived: sum of 4 quarters · filed 2018-03-08
2015-12-31$2.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
$4.27M
derived: sum of 2 quarters · filed 2018-03-08
$6.04M
derived: sum of 3 quarters · filed 2018-03-08
$7.53M
10-K · filed 2018-03-08
2015-09-30$1.87M
10-Q · filed 2016-11-04
$3.64M
derived: sum of 2 quarters · filed 2016-11-04
$5.13M
10-Q · filed 2016-11-04
$5.40M
derived: sum of 4 quarters · filed 2017-03-10
2015-06-30$1.77M
10-Q · filed 2016-08-05
$3.26M
10-Q · filed 2016-08-05
$3.53M
derived: sum of 3 quarters · filed 2017-03-10
$3.77M
derived: sum of 4 quarters · filed 2017-03-10
2015-03-31$1.49M
10-Q · filed 2016-05-06
$1.76M
derived: sum of 2 quarters · filed 2017-03-10
$2.00M
derived: sum of 3 quarters · filed 2017-03-10
$3.01M
derived: sum of 4 quarters · filed 2017-03-10
2014-12-31$270.82K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10
$508.18K
derived: sum of 2 quarters · filed 2017-03-10
$1.53M
derived: sum of 3 quarters · filed 2017-03-10
$2.05M
10-K · filed 2017-03-10
2014-09-30$237.36K
10-Q · filed 2015-11-10
$1.26M
derived: sum of 2 quarters · filed 2015-11-10
$1.78M
10-Q · filed 2015-11-10
$2.25M
derived: sum of 4 quarters · filed 2015-11-10
2014-06-30$1.02M
10-Q · filed 2015-08-11
$1.54M
10-Q · filed 2015-08-11
$2.02M
derived: sum of 3 quarters · filed 2015-08-11
$2.28M
derived: sum of 4 quarters · filed 2015-08-11
2014-03-31$523.37K
10-Q · filed 2015-05-11
$997.35K
derived: sum of 2 quarters · filed 2015-05-11
$1.26M
derived: sum of 3 quarters · filed 2015-05-11
$1.82M
derived: sum of 4 quarters · filed 2015-05-11
2013-12-31$473.98K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23
$734.65K
derived: sum of 2 quarters · filed 2015-03-23
$1.29M
derived: sum of 3 quarters · filed 2015-03-23
$1.94M
10-K · filed 2015-03-23
2013-09-30$260.68K
10-Q · filed 2014-11-13
$818.98K
derived: sum of 2 quarters · filed 2014-11-13
$1.46M
10-Q · filed 2014-11-13
2013-06-30$558.31K
10-Q · filed 2014-08-14
$1.20M
10-Q · filed 2014-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
ARTIVION, INC. (AORT)United States$1.123B-345.09
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02